Article View: sci.crypt
Article #2361Re: Public Key Patents
From: jac54
Date: Mon, 23 Nov 1992 16:57
Date: Mon, 23 Nov 1992 16:57
19 lines
1344 bytes
1344 bytes
In article <1992Nov23.011349.11673@netcom.com> rlglende@netcom.com (Robert Lewis Glendenning) writes: >I believe that Fleming made the patent for penicillin public, which delayed >development for many years. No drug company wanted to invest the $ >on development and clinical testing when anybody else could ride on >the investment and undercut their prices. A sure route to bankruptcy. > >This is a system design issue. You guys are argueing about waves, >not wave-generation mechanisms. > Of course he made the patent public. A patent is a public record of an invention. The claims describe an invention over which the inventor has the right to prevent anyone else practicing and therefore have to publicly described. The reason for the delay in the commercial development of penicillin was more likely the very mixed set of clinical trials. Alec Chambers
Technical Details
Message-ID:
<1992Nov23.165703.21735@cas.org>Path:
arc1-ca.pugleaf.net!sparky!uunet!zaphod.mps.ohio-state.edu!malgudi.oar.net!chemabs!jac54References:
<1ebjbsINNgfv@iskut.ucs.ubc.ca> <PHR.92Nov19225721@napa.telebit.com> <1992Nov23.011349.11673@netcom.com>Show Full Headers
Complete Article Headers
Newsgroups: sci.crypt Path: arc1-ca.pugleaf.net!sparky!uunet!zaphod.mps.ohio-state.edu!malgudi.oar.net!chemabs!jac54 From: jac54@cas.org () Subject: Re: Public Key Patents Message-ID: <1992Nov23.165703.21735@cas.org> Sender: usenet@cas.org Organization: Chemical Abstracts Service, Columbus, Ohio References: <1ebjbsINNgfv@iskut.ucs.ubc.ca> <PHR.92Nov19225721@napa.telebit.com> <1992Nov23.011349.11673@netcom.com> Date: Mon, 23 Nov 1992 16:57:03 GMT Lines: 19